Zephyrnet Logo

Tag: Vice President

New Integrated Telematics for Fleet Managers Coming to Jeep, Ram, Dodge and Chrysler

Geotab has partnered with Stellantis to deliver integrated telematics to U.S. models

NFL Embraces Gambling by Searching for Sports Betting Vice President/General Manager

The NFL is taking another step in integrating sports betting and its usual operations by searching for a GM and VP of betting.

The post NFL Embraces Gambling by Searching for Sports Betting Vice President/General Manager appeared first on VegasSlotsOnline News.

Caesars Sportsbook to Launch Racebook App With NYRA

Caesars Sportsbook will launch its Caesars Racebook app this spring in partnership with NYRA Bets LLC, the New York Racing Association’s official online horse racing wagering platform.

The post Caesars Sportsbook to Launch Racebook App With NYRA appeared first on VegasSlotsOnline News.

Bypassing outrageous limits in Windows 11’s new video editing app isn’t cheap

Zeta partners Mastercard to shake up credit card issuance

The payments giant has also invested $30 million, alongside other investors, into Zeta.

A Humanitarian Flight of Air Canada Flies Through Poland to Provide Aid to Ukraine

Medical equipment and supplies from Canadian NGOs were successfully transferred to Ukraine conflict victims through Warsaw, Poland, on a special Air Canada Boeing 787-9 humanitarian cargo charter trip. Tons of much-needed equipment, such as medical beds, plastic mattresses, and other […]

Citi Director Leaves To Start Own Crypto Company

The former co-head of digital assets said he wanted to assist in the maturation of the crypto market via a new venture

The post Citi Director Leaves To Start Own Crypto Company appeared first on Blockworks.

Episode 307: Women shaping the future of climate action, finance and ESG

Plus, a quick catch up with Dylan Siegler, vice president and senior sustainability analyst at GreenBiz.

Wolters Kluwer acquires International Document Services in $70m deal

IDS is expected to generate revenues worth approximately $15 million in 2022.

Eisai to Present New Lecanemab Data Exploring Distinct Mechanism of Action and Clinical Outcomes, Disease State (DSE) Symposium, and Other Pipeline Assets at the...

TOKYO, Mar 11, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced today the company will present research from its robust Alzheimer's disease (AD) pipeline, including the latest findings on lecanemab, Eisai's investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of early AD at the AD/PD 2022 International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) from March 15-20 in Barcelona, Spain and virtually.

The lecanemab data and additional research findings from Eisai's clinical development programs will be featured in 13 presentations. Lecanemab was granted Breakthrough Therapy and Fast Track designations by the U.S. Food and Drug Administration (FDA) in June and December 2021, respectively. Eisai anticipates completing lecanemab's rolling submission of a Biologics License Application for the treatment of early AD to the FDA under the accelerated approval pathway in the first quarter of Eisai's fiscal year 2022, which begins April 1, 2022. Additionally, the readout of the Phase 3 confirmatory Clarity AD clinical trial will occur in the Fall of 2022. Eisai initiated a submission to the Pharmaceuticals and Medical Devices Agency (PMDA) of application data of lecanemab under the prior assessment consultation system in Japan in March 2022.

"Four key presentations at AD/PD 2022 advance our understanding of the mechanism of action of Eisai's investigational anti- Abeta protofibril antibody lecanemab and the therapy's clinical and safety profile, including amyloid related imaging abnormalities, or ARIA, from the Phase 2b study and open-label extension, in the potential treatment of early Alzheimer's disease," said Michael Irizarry, M.D., Senior Vice President, Deputy Chief Clinical Officer, Neurology Business Group, Eisai Inc. "In addition to lecanemab, Eisai's robust pipeline includes compounds targeting the tau pathway, other pathways leading to neurodegeneration, and the testing of combination therapies that may be the optimal approach to treat or even prevent Alzheimer's disease."

The focus on AD has historically been on alleviating cognitive, functional, and behavioral symptoms, but there has been significant progress in understanding the biological mechanisms of the disease. Eisai's investigational pipeline aims to treat the range of underlying pathophysiology, including amyloid, tau and neurodegeneration.

"Because of the robust design of the lecanemab Phase 2b study, Eisai was able to design the Phase 3 confirmatory Clarity AD clinical trial to optimally verify lecanemab's clinical efficacy and safety in early Alzheimer's disease," said Ivan Cheung, Chairman, Eisai Inc., Senior Vice President, President Neurology Business Group and Global Alzheimer's Disease Officer, Eisai Co., Ltd. "Part of the recruitment strategy for the Clarity AD confirmatory trial was to ensure greater inclusion of ethnic and racial populations. While there is still important work to be done in ensuring minority populations' participation in clinical trials, Eisai is proud that approximately 25% of the total U.S. enrollment in Clarity AD consists of African American and Hispanic persons living with early Alzheimer's disease, which mirrors the U.S. Medicare population."

This release discusses investigational uses of an agent in development and is not intended to convey conclusions about efficacy or safety. There is no guarantee that such investigational agent will successfully complete clinical development or gain health authority approval.

For more information, visit https://www.eisai.com/news/2022/news202218.html.


Copyright 2022 JCN Newswire. All rights reserved. www.jcnnewswire.comEisai Co., Ltd. announced today the company will present research from its robust Alzheimer's disease (AD) pipeline, including the latest findings on lecanemab, Eisai's investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of early AD at the AD/PD 2022 International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) from March 15-20 in Barcelona, Spain and virtually.

Telefonica Vivo Launches 5G-Ready IP Transport Network with Cisco and NEC to Provide Seamless Connections Across Brazil

SÃO PAULO, Brazil, SAN JOSE, Calif., and TOKYO, Japan , Mar 11, 2022 - (JCN Newswire) - Cisco and NEC Corporation today announced that Telefonica Vivo is deploying a simplified and automated, 5G-ready IP network for its converged mobile and fixed networks as part of the Fusion Network Project in Brazil supported by industry-leading solutions from the vendors. Cisco and NEC have been closely collaborating in Brazil for over 10 years and now are a part of a Global System Integrator Agreement (GSIA) signed in 2020, enabling them to seamlessly deploy an automated transport 5G-ready network for Telefonica Vivo.

Telefonica designed the Fusion Network Project as a platform for incorporating services into a single network infrastructure, offering advanced communications services, and transforming the customer experience. Leveraging the power of automation, the project aims to offer a more agile, scalable, and flexible network with improved reliability for both residential users and enterprises in the 5G era.

As defined in the Fusion Network Project, Cisco and NEC will work together to optimize Telefonica Vivo's total cost of ownership (TCO) and increase business agility by simplifying its network architecture and operations, converging mobile and fixed networks, and automating multi-layer networks across packet, optical and microwave domains. In addition, Segment Routing IPv6 will be implemented to enable a unified architecture with network slicing capabilities.

The simplification and automation of a multi-domain, multi-layer converged network coupled with segment routing, will increase Telefonica Vivo's network scalability and flexibility as it prepares to launch 5G. The Fusion Network Architecture will provide the scalability and flexibility needed to design and deliver new services.

As part of the agreement, Cisco will provide industry-leading network equipment including ASR 9000 and NCS 540 series routers for IP transport, Cisco Crosswork Network Controller as the multi-vendor SDN solution, and Cisco Crosswork Hierarchical Controller to enable multi-vendor and multi-layer automation within the Fusion Network domain. Cisco will serve as the key networking advisor leveraging a long-standing relationship and in-depth understanding of Telefonica Vivo's network.

Also building on a strong relationship and knowledge of the Telefonica Vivo network, NEC will serve as the key network integrator and provide local engineering capabilities with 5G xHaul transformation services to deliver a scalable migration for thousands of nodes.

"Since the transport network will play a key role in supporting innovative customer experiences and new services built on 5G, we needed trusted partners with a solid track record and local delivery capabilities," said Elmo Matos, Planning Director, Telefonica Vivo.

"Building on our partnership with NEC, we are pleased to enable Telefonica Vivo in providing faster, more seamless connections through a more modern, simplified network," said Shaun McCarthy, Vice President of Worldwide Sales, Mass Infrastructure Group, Cisco. "It is a great honor for Cisco to help be the bridge that is bringing the Internet for the Future to Brazil."

"NEC is honored to be selected as key partner for the Fusion Network Project, which is foundational to blossoming digital experiences in 5G," said Mayuko Tatewaki, General Manager, Service Provider Solutions Division, NEC Corporation. "With Cisco's trusted solutions combined into NEC's 5G xHaul Automation Ecosystem and further extended by our network integration capabilities globally and regionally, we are confident the implementation of the next-gen network will help deploy immersive 5G services in Brazil."

About Telefonica

Telefonica is a leading telecommunications service provider globally. The company offers fixed and mobile connectivity, as well as a wide range of digital services for individual consumers and enterprises. Telefonica has 367 million clients spanning Europe and Latin America. Telefonica is a private company whose shares are listed as TEF on the Bolsa de Madrid, the New York Stock Exchange, and the Bolsa de Valores de Lima.

https://www.telefonica.com/es/home

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide leader in technology that powers the Internet. Cisco inspires new possibilities by reimagining your applications, securing your data, transforming your infrastructure, and empowering your teams for a global and inclusive future.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at new windowwww.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.


Copyright 2022 JCN Newswire. All rights reserved. www.jcnnewswire.comCisco and NEC Corporation today announced that Telefonica Vivo is deploying a simplified and automated, 5G-ready IP network for its converged mobile and fixed networks as part of the Fusion Network Project in Brazil supported by industry-leading solutions from the vendors.

PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board

Silicon Valley luminaries, led by Apple alumnus and NeXT Computer co-founder Rich Page, to support the company’s technology development, data and analytics, and consumer engagement strategy NEW YORK–(BUSINESS WIRE)–$PAVM #DigitalHealth—PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company today announced that its majority-owned digital health subsidiary Veris Health (“Veris”) has launched a […]

The post PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board appeared first on Fintech News.

Latest Intelligence

spot_img
spot_img